Cloud9 Technologies Lands New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d6e22d91-2ea0-4f38-b3dc-3e3ebbdd553a Date 4/14/2016 Company Name Cloud9 Technologies Mailing Address 565 5th Avenue New York, NY 10017 USA Company Description Cloud 9 Technologies is a cloud communications service provider. We provide high performance voice, messaging and collaboration services designed for the unique needs of distributed work groups and teams. We deliver our services … Continue reading “Cloud9 Technologies Lands New Round”

HookLogic Obtains New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=18ff8365-ca35-42ae-bea6-7f4fc5f2522e Date 4/14/2016 Company Name HookLogic Mailing Address 99 Hudson Street 9th Floor New York, NY 10013 USA Company Description Brands can reach shoppers, drive traffic, and attribute sales through this performance marketing platform spanning the largest retail and travel sites. Website http://www.hooklogic.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round … Continue reading “HookLogic Obtains New Financing Round”

Ovid Therapeutics Names Former Biogen Exec New CMO

New York-based Ovid Therapeutics has named Amit Rakhit, a former Biogen and Bristol-Myers Squibb executive, its chief medical and portfolio management officer. The company has also added Daniel Geschwind, a neurology and psychiatry professor at UCLA School of Medicine, to its scientific advisory board. Check out this story for more on Ovid, which is developing … Continue reading “Ovid Therapeutics Names Former Biogen Exec New CMO”

With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets

Harvard University chemical biologist and serial entrepreneur Greg Verdine has spent more than a decade trying to come up with different solutions for one critical problem in biotech: The majority of would-be drug targets are out of reach of existing technologies. That drive has already led to several different companies—among them Aileron Therapeutics, Warp Drive … Continue reading “With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets”

NodeSource Obtains $10,000,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=67aa20b7-5be2-4fc4-8b8d-2f2e10729f28 Date 4/13/2016 Company Name NodeSource Mailing Address Undisclosed New York, NY 10001 USA Company Description NodeSource is a technology company that delivers enterprise-grade tools and software targeting the unique needs of running server-side JavaScript at scale. Website http://www.nodesource.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Series A Proceeds Purposes … Continue reading “NodeSource Obtains $10,000,000 Series A Financing Round”

CareDox Receives $2,800,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6370f738-6010-412d-8ce6-6fccb32a21c8 Date 4/13/2016 Company Name CareDox Mailing Address 35 West 35th Street 10th Floor New York, NY 10001 USA Company Description CareDox is a care coordination platform for parents and schools. Website http://www.caredox.com Transaction Type Venture Equity Transaction Amount $2,800,000 Transaction Round Seed Proceeds Purposes With this funding, CareDox will continue their … Continue reading “CareDox Receives $2,800,000 Seed Round”

CloudEndure Garners $6,000,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5fe16e34-b9b2-4339-a59c-969fa1cecbe8 Date 4/13/2016 Company Name CloudEndure Mailing Address 244 5th Avenue New York, NY 10001 USA Company Description Cloud migration and disaster recovery for any application, using continuous replication of your entire application stack Website http://www.cloudendure.com Transaction Type Venture Equity Transaction Amount $6,000,000 Transaction Round Series B Proceeds Purposes The additional funding … Continue reading “CloudEndure Garners $6,000,000 Series B Financing Round”

MediQuire Receives Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3d3a22f0-fd06-4c98-a57b-b227ea430ce9 Date 4/13/2016 Company Name MediQuire Mailing Address 333 West 39th Street New York, NY 10018 USA Company Description MediQuire aims to transform the health of the Medicaid population by bringing together medical, behavioral, financial and social data and using advanced analytics to understand how to improve patient outcomes while reducing cost. … Continue reading “MediQuire Receives Series A Financing”

CareDox Obtains $1,500,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5292e71a-e853-4fe8-af0c-f166d94bfdb9 Date 4/13/2016 Company Name CareDox Mailing Address 35 West 35th Street 10th Floor New York, NY 10001 USA Company Description CareDox is a care coordination platform for parents and schools. Website http://www.caredox.com Transaction Type Debt Transaction Amount $1,500,000 Transaction Round Undisclosed Proceeds Purposes With this funding, CareDox will continue their focus … Continue reading “CareDox Obtains $1,500,000 New Funding Round”

Vacca, Sekhri Join Versant’s Manhattan Biotech Incubator

Versant Ventures has appointed Joe Vacca and Paul Sekhri to executive roles at Highline Therapeutics, the firm’s Manhattan-based biotech startup incubator. Vacca, a Merck veteran, has joined up as Highline’s chief scientific officer. Sekhri, currently the president and CEO of Lycera—which Celgene has an option to acquire—has been named an operating partner at Highline. The … Continue reading “Vacca, Sekhri Join Versant’s Manhattan Biotech Incubator”

Shapeways CEO Calls Again for 3D Printing Revolution in Manufacturing

At this afternoon’s Inside 3D Printing Conference & Expo held in New York, Shapeways CEO and co-founder Peter Weijmarshausen will give a keynote address on the potential he sees in the long-promised age of digital manufacturing—which, frankly, still has a ways to go before it takes hold with the masses. Shapeways, based in New York, produces 3D-printed … Continue reading “Shapeways CEO Calls Again for 3D Printing Revolution in Manufacturing”

Impraise Garners $1,600,000 Seed Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7dd26af3-307a-4c6c-b4c2-2332351ae88f Date 4/12/2016 Company Name Impraise Mailing Address 424 Broadway New York, NY 10013 USA Company Description Real-time Feedback, modern 360 Degree Feedback and Performance Review Software. Make employee feedback continuous and meaningful. Website http://www.impraise.com Transaction Type Venture Equity Transaction Amount $1,600,000 Transaction Round Seed Proceeds Purposes Proceeds purposes were not disclosed … Continue reading “Impraise Garners $1,600,000 Seed Financing”

MedPilot Secures $750,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6351cc70-460a-4078-a009-572c84f4648d Date 4/12/2016 Company Name MedPilot Mailing Address 2 447 Broadway New York, NY 10013 USA Company Description Traditional patient outreach through phone calls and letters costs time and money. Our rules-based engine times and triggers messages to provide a more efficient and personalized approach. Website http://www.medpilot.com Transaction Type Venture Equity Transaction … Continue reading “MedPilot Secures $750,000 New Financing Round”

CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue

Intellia Therapeutics, a developer of human medicines based on the gene editing technology CRISPR-Cas9, has thrown its hat in the IPO ring. It’s also shooting directly at the liver. The Cambridge, MA-based company filed paperwork to go public today. It also announced a deal with Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: [[ticker:REGN]]) to develop a therapy … Continue reading “CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue”

Techstars Gets Industrial With Launch of IoT Accelerator in New York

Trying a different strategy to nurture startups in the Internet of Things niche, Techstars announced on Monday the formation of another accelerator that will be based in New York. Ten spots are up for grabs for startups in the new program, which is another effort by Boulder, CO-based Techstars to foster companies working on ideas that connect … Continue reading “Techstars Gets Industrial With Launch of IoT Accelerator in New York”

Five Takeaways from “What’s Hot in Boston Biotech”

“What’s Hot in Boston Biotech” can change with the wind. One week it might be a multi-billion dollar buyout, the next a high profile startup. Keeping up with the latest high-flying companies and issues can be tricky when you’re running an event in one of biotechnology’s epicenters. This year, before a packed house at Biogen’s … Continue reading “Five Takeaways from “What’s Hot in Boston Biotech””

A Pivotal Factor In M&A Deals: Cyber Risk

Big merger and acquisition proposals trigger intense examinations of the benefits and risks of the deal from both sides—valuations, assets, legal liabilities, operational risk exposures, and compatibility, among others. However, it is also critical that companies elevate another factor to the top of the priority list: their cyber risk exposure. The pending acquisition of Starwood … Continue reading “A Pivotal Factor In M&A Deals: Cyber Risk”

Homemade Lands $2,100,000 Seed Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6c1461a-1f45-47b6-a585-c73322d79e1f Date 4/11/2016 Company Name Homemade Mailing Address 64 Delancey Street New York, NY 10002 USA Company Description Homemade is a marketplace for home cooked food. Buy unique Homemade food from local cooks near you. Website http://www.gethomemade.co Transaction Type Venture Equity Transaction Amount $2,100,000 Transaction Round Seed Proceeds Purposes The company will … Continue reading “Homemade Lands $2,100,000 Seed Funding Round”

Meural Garners $2,055,351 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5b066e9c-9e88-4f96-a0b9-cb34d028b5d0 Date 4/11/2016 Company Name Meural Mailing Address 902 Broadway 6th Floor New York, NY 10010 USA Company Description Meural combines the best of art, technology, and design to create products that make us feel something. We believe that the best products come from a humanistic design approach. Meural incorporates culture, craft, … Continue reading “Meural Garners $2,055,351 New Round”

Steve Case’s Rules for Building Startups in Internet’s “Third Wave”

Software could be poised to truly transform entrenched sectors like healthcare, education, financial services, and more. But the next wave of software companies will take longer to build than some entrepreneurs have grown accustomed to in the smartphone era, and success will require more patience and willingness to work closely with policymakers and industry stakeholders. … Continue reading “Steve Case’s Rules for Building Startups in Internet’s “Third Wave””

East Coast Biotech Roundup: PfizerGan, Nimbus, Intercept, Tesaro & More

This past week started out with a big alliance between Gilead Sciences and Nimbus Therapeutics in one of biotech’s biggest contests—the race to treat nonalcoholic steatohepatitis, or NASH. Those who packed Biogen on Wednesday for our biotech forum, “What’s Hot in Boston Biotech,” got an inside look at what led to that deal and where … Continue reading “East Coast Biotech Roundup: PfizerGan, Nimbus, Intercept, Tesaro & More”

The Case For An Internet Franchise Model

Internet service in America is not what it should be. Most consumers have two choices for access: the phone company or the cable company. By a quirk of fate, networks built with cables designed for television service can deliver more Internet bandwidth than networks built with cables designed for telephone service. So, the cable company … Continue reading “The Case For An Internet Franchise Model”

ELOQUII Secures $15,000,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=29f025e6-9ce6-414f-a060-1423b74529c7 Date 4/8/2016 Company Name ELOQUII Mailing Address Ohio Street Columbus, NY 43219 USA Company Description Visit our online plus size clothing store featuring women’s plus size fashion, clothes and accessories. Shop confidently. Website http://www.eloquii.com Transaction Type Venture Equity Transaction Amount $15,000,000 Transaction Round Series B Proceeds Purposes This funding round builds … Continue reading “ELOQUII Secures $15,000,000 Series B Funding”

Advisory Panel Backs Intercept’s Liver Drug, FDA Ruling up Next

A panel of FDA advisors gave a thumbs-up today to obeticholic acid, a drug from New York-based Intercept Pharmaceuticals (NASDAQ: [[ticker:ICPT]]) that the agency is considering as a treatment for a rare autoimmune liver disease. The outside advisors, mainly medical specialists from around the U.S., recommended that the FDA approve obeticholic acid, or OCA, by … Continue reading “Advisory Panel Backs Intercept’s Liver Drug, FDA Ruling up Next”

How Startups Can Run Better Landing Page Tests

In today’s fast-changing world, new product teams are constantly pushed to do more faster. They need to run fast to keep up with rapidly changing market conditions. Oftentimes it means making decisions about what to invest in with very little information. How can teams validate hypotheses without over-investing on speculative engineering projects, and potentially losing … Continue reading “How Startups Can Run Better Landing Page Tests”

X.ai Obtains $23,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e3ef7176-3480-4261-9058-6417b0a39feb Date 4/7/2016 Company Name X.ai Mailing Address 48 Wall Street 5th Floor New York, NY 10005 USA Company Description x.ai is a personal assistant who schedules meetings for you. Website http://www.x.ai Transaction Type Venture Equity Transaction Amount $23,000,000 Transaction Round Undisclosed Proceeds Purposes The additional $23 million will accelerate development of … Continue reading “X.ai Obtains $23,000,000 New Funding Round”

Planday Lands $14,000,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=30aa3f9c-158d-4f6f-a6be-6c28946ce80c Date 4/7/2016 Company Name Planday Mailing Address 77 N 4th Street Brooklyn, NY 11249 USA Company Description Planday bring down staff costs by 5%, reduce administration time by 75% and increase employee satisfaction by 20%. Website http://www.planday.com Transaction Type Venture Equity Transaction Amount $14,000,000 Transaction Round Series B Proceeds Purposes Planday … Continue reading “Planday Lands $14,000,000 Series B Financing”

Dispatch Garners $2,000,000 Seed Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e5bf34c-10f9-4466-9cf5-6f4ba1975b14 Date 4/7/2016 Company Name Dispatch Mailing Address 900 Broadway New York, NY 10003 USA Company Description Dispatch is creating a platform for local delivery powered by a fleet of autonomous vehicles designed for sidewalks and pedestrian spaces. Website http://www.dispatch.ai Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Seed Proceeds Purposes … Continue reading “Dispatch Garners $2,000,000 Seed Financing Round”

Allergan, Pfizer Cancel $160B Merger, Citing U.S. Treasury Actions

The speculation turned out to be true: Pfizer and Allergan announced today that they are canceling a proposed $160 billion merger, in large part due to steps the U.S. Treasury Department is planning to prevent tax avoidance. Their stock prices started swinging late Monday as the companies began reviewing the new rules released that day by … Continue reading “Allergan, Pfizer Cancel $160B Merger, Citing U.S. Treasury Actions”

Announcing Xconomy Indiana—11th Region in Our Network

Just over two years ago, when we launched Xconomy Wisconsin as the ninth region in our network, I wrote: “There are no flyover zones in the United States. That’s the way Xconomy views the map, anyway, because we see innovation happening all over America.” Since that time, we expanded again, to Raleigh-Durham. And I am … Continue reading “Announcing Xconomy Indiana—11th Region in Our Network”

As Rivals Make News, Intercept Heads To Daylong Hearing For Liver Drug

Tuesday morning, FDA scientists published a thick document describing their view of the drug obeticholic acid as a treatment for a rare form of liver disease called primary biliary cirrhosis. With that document in mind, a panel of outside advisors will spend Thursday grilling the drug’s maker, New York-based Intercept Pharmaceuticals (NASDAQ: [[ticker:ICPT]]), and recommend … Continue reading “As Rivals Make News, Intercept Heads To Daylong Hearing For Liver Drug”

Sawyer Obtains $1,500,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9625b9a8-e4e4-4204-983a-484129759b93 Date 4/6/2016 Company Name Sawyer Mailing Address Undisclosed Brooklyn, NY 11201 USA Company Description There’s no such thing as playing without learning. That’s why a world rich with sounds and sights is proven to spur cognitive, social, and physical growth during the critical early childhood development years. So if your little … Continue reading “Sawyer Obtains $1,500,000 New Funding Round”

Happy Returns Garners $1,900,000 Seed Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=684c0636-c2a2-4373-b55a-9923c0070609 Date 4/6/2016 Company Name Happy Returns Mailing Address 25 S Main St Gloversville New York, NY 12078 USA Company Description Online shoppers overwhelmingly prefer to return in person. When given the choice, shoppers prefer to return online purchases in person to avoid the hassle and wait of returns by mail. Website … Continue reading “Happy Returns Garners $1,900,000 Seed Financing”

Immelt Puts Human Face, and Dollar Amounts, on GE’s Move to Boston

On any other day, the State Room on the 33rd floor of 60 State Street would afford sweeping views of Boston’s financial district, state house, and waterfront. But on Monday, it was shrouded in a snow squall—a reminder that few things come easy in New England, least of all springtime. Inside the room, elite politicians … Continue reading “Immelt Puts Human Face, and Dollar Amounts, on GE’s Move to Boston”

Software Study Ranks San Diego #7, Cites Prowess in Scientific R&D

A study to assess the strength of San Diego’s software sector has determined that it ranks seventh among the top 50 U.S. metropolitan areas, according to a “software power index” that weighs a variety of economic factors. The study, released last week by the San Diego Regional Economic Development Corp., is the first comprehensive analysis … Continue reading “Software Study Ranks San Diego #7, Cites Prowess in Scientific R&D”

Making the Price Right: Ideas To Change Drug Costs Gain Momentum

If the U.S. presidential primaries continue their current trajectories, the two contenders come autumn will have at least one thing in common: a stated desire to do something about high drug prices. Maybe you believe them, and maybe you think they’re blowing smoke up our nether regions. But momentum is momentum. With consumers, doctors, and … Continue reading “Making the Price Right: Ideas To Change Drug Costs Gain Momentum”

New York’s Life Science Disruptors: The Photos

Last week, we held our yearly Big Apple biotech event, “New York’s Life Science Disruptors,” which provides an inside look at the people and companies that are shaping the emerging life sciences scene in the city. As per usual, today I’m circling back with the photos. Just wanted to say thanks again to all the folks … Continue reading “New York’s Life Science Disruptors: The Photos”

Persado Receives $30,000,000 Series C Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b184d953-644d-40dd-beeb-8f736167b12b Date 4/5/2016 Company Name Persado Mailing Address 50 West 17th Street 11th Floor New York, NY 10011 USA Company Description Persado is the leader in marketing persuasion technology, a new category within digital marketing. The company provides marketing software through a managed SaaS platform to leading enterprise and Internet consumer marketers, … Continue reading “Persado Receives $30,000,000 Series C Funding”

Influenster Garners $8,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2baec864-42e3-43dc-aa99-b92d61cd2374 Date 4/5/2016 Company Name Influenster Mailing Address 285 West Broadway New York, NY 10013 USA Company Description Influenster is a product discovery platform and review site that enables consumers to find new products to try and get advice so they can make informed purchases. Website http://www.influenster.com Transaction Type Venture Equity Transaction … Continue reading “Influenster Garners $8,000,000 Series A Round”

Peerbridge Health Receives $1,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a0f3fcd1-517b-48ac-8636-d2663e67b70d Date 4/5/2016 Company Name Peerbridge Health Mailing Address 110 E 59th St. New York, NY 10022 USA Company Description To set new standards offering medical grade data via wearable technology solutions; providing access and improving the lives of patients, athletes and those committed to health and well-being. Website http://www.peerbridgehealth.com Transaction Type … Continue reading “Peerbridge Health Receives $1,000,000 New Funding”

Verizon, Cornell Tech, and CUNY Form NY Women in Tech Initiative

Bringing together public and private support, a tech education program has taken shape in New York to encourage more women to get trained to pursue careers in the industry. Verizon Communications, alongside Cornell Tech and the City University of New York, recently announced the Women in Technology and Entrepreneurship in New York Initiative (WiTNY)—which aims … Continue reading “Verizon, Cornell Tech, and CUNY Form NY Women in Tech Initiative”

Napa Summit 2016: Request Your Invite to Our Most Special Event

There are all sorts of reasons for requesting an invitation to Xconomy’s Napa Summit, which will take place in just six weeks—on May 16-17.  One is the fantastic array of speakers: John Maeda, design partner at Kleiner, Perkins, Caufield, and Byers; virtual reality virtuoso Mary Lou Jepsen of Facebook/Oculus; tech investor Esther Dyson; computing visionary … Continue reading “Napa Summit 2016: Request Your Invite to Our Most Special Event”

Celmatix Lands $4,799,999 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c018e6ec-d305-45f7-b092-ebae9d2d3a8e Date 4/4/2016 Company Name Celmatix Mailing Address 54 West 40th Street New York, NY 10018 USA Company Description Celmatix uses big data analytics and genomics to improve fertility treatments and pave the way for proactive fertility management. Website http://www.celmatix.com Transaction Type Venture Equity Transaction Amount $4,799,999 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Celmatix Lands $4,799,999 New Round”

Reserve Acquires Dash for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c28305f9-70c1-4982-921b-4f656e8d5e0c Date 4/4/2016 Company Name Dash Mailing Address 130 William Street Brooklyn, NY 10038 USA Company Description Dash is a new way to pay at bars and restaurants. Using your phone, you can check-in at a Dash venue, view your bill, split it with friends, and pay with one tap. We care … Continue reading “Reserve Acquires Dash for Undisclosed Sum”

At Long Last, First Drug Approval in Sight for Amicus

It’s an understatement to call Amicus Therapeutics’ quest to get its first drug approved a roller coaster ride. But it looks like the twists and turns might soon be over for the Cranbury, NJ-based company—at least in Europe. The committee of medicinal products for human use (CHMP) on Friday recommended approval of Amicus’s (NASDAQ: [[ticker:FOLD]]) … Continue reading “At Long Last, First Drug Approval in Sight for Amicus”

When Data Meets Genomics, Where Does Computing Power Come From?

San Antonio—Even as genome sequencing has risen in prevalence and declined in cost during the last decade, it still has many scientists perplexed from a data standpoint. As it becomes more common for pharmaceutical and biotech companies to use data from sequenced genomes for drug testing, the question of how will they effectively process that … Continue reading “When Data Meets Genomics, Where Does Computing Power Come From?”

East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More

Our East Coast drive started in New York this week, where we took a close look at the state of the city’s biotech ecosystem and the road ahead through the eyes of some of the area’s scientific entrepreneurs and investors. Over in the suburbs, Regeneron Pharmaceuticals’ partnership with Sanofi continued to pay dividends, with some … Continue reading “East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More”